FDA.reportPublic FDA data

30 ML idecabtagene vicleucel 17000000 CELLS/ML Injection [Abecma]

RxCUI
2536439
RxNorm name
30 ML idecabtagene vicleucel 17000000 CELLS/ML Injection [Abecma]
Display name
30 ML idecabtagene vicleucel 17000000 CELLS/ML Injection [Abecma]
Full name
30 ML idecabtagene vicleucel 17000000 CELLS/ML Injection [Abecma]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125736Abecmaidecabtagene vicleucel351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AbecmaIDECABTAGENE VICLEUCELCelgene Corporationb90c1fe7-f5cc-464e-958a-af36e9c26d7c2025-11-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2536439

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b90c1fe7-f5cc-464e-958a-af36e9c26d7c30 ML idecabtagene vicleucel 17000000 CELLS/ML Injection [Abecma]SBD19These highlights do not include all the information needed to use ABECMA safely and effectively. See full prescribing information for ABECMA. ABECMA ® (idecabtagene vicleucel), suspension for intravenous infusion Initial U.S. Approval: 202120251125
b90c1fe7-f5cc-464e-958a-af36e9c26d7c30 ML Abecma 17000000 CELLS/ML InjectionSY19These highlights do not include all the information needed to use ABECMA safely and effectively. See full prescribing information for ABECMA. ABECMA ® (idecabtagene vicleucel), suspension for intravenous infusion Initial U.S. Approval: 202120251125
b90c1fe7-f5cc-464e-958a-af36e9c26d7cAbecma 510,000,000 CELLS per 30 ML InjectionSY19These highlights do not include all the information needed to use ABECMA safely and effectively. See full prescribing information for ABECMA. ABECMA ® (idecabtagene vicleucel), suspension for intravenous infusion Initial U.S. Approval: 202120251125
b90c1fe7-f5cc-464e-958a-af36e9c26d7cAbecma 17000000 CELLS/ML per 30 ML InjectionSY19These highlights do not include all the information needed to use ABECMA safely and effectively. See full prescribing information for ABECMA. ABECMA ® (idecabtagene vicleucel), suspension for intravenous infusion Initial U.S. Approval: 202120251125
b90c1fe7-f5cc-464e-958a-af36e9c26d7cAbecma 510,000,000 CELLS in 30 ML InjectionPSN19These highlights do not include all the information needed to use ABECMA safely and effectively. See full prescribing information for ABECMA. ABECMA ® (idecabtagene vicleucel), suspension for intravenous infusion Initial U.S. Approval: 202120251125